(NASDAQ: RMTI) Rockwell Medical's forecast annual revenue growth rate of 1.43% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 3,810.05%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,542.52%.
Rockwell Medical's revenue in 2026 is $75,577,000.On average, 4 Wall Street analysts forecast RMTI's revenue for 2026 to be $3,020,652,830, with the lowest RMTI revenue forecast at $2,865,671,777, and the highest RMTI revenue forecast at $3,148,601,846.
In 2027, RMTI is forecast to generate $3,131,736,376 in revenue, with the lowest revenue forecast at $3,008,949,455 and the highest revenue forecast at $3,223,865,973.